Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In this review, we review the evidence supporting combined SGLT2i and GLP-1RA therapy in type 2 diabetes with a focus on cardiometabolic outcomes, and we propose a pragmatic framework for clinical use
This information can help the doctor understand what is happening and decide the best course of action
Dosage Calculator
Unfortunately, these warnings may fall short of alerting patients and doctors to the full extent of the risks associated with this drug
doi: 10.1097/01.AOG.0000231688.08263.47 8 ZinmanBWannerCLachinJMFitchettDBluhmkiEHantelSet al
Lancet 392:15191529 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydn L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T (2019) REWIND Investigators
